Free shipping on all orders over $ 500

Candesartan Cilexetil

Cat. No. M3570

All AbMole products are for research use only, cannot be used for human consumption.

Candesartan Cilexetil Structure
Synonym:

TCV-116

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
100mg USD 25  USD25 In stock
500mg USD 50  USD50 In stock
1g USD 80  USD80 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Candesartan cilexetil is a specific nonpeptide Ang II receptor (ATR) antagonist and the prodrug of candesartan which is an ATR antagonist with an IC50 of 15 µg/kg. Candesartan cilexetil efficacy is entirely due to its active metabolite candesartan (CV-11794) and is dose-dependent over the range of 1–8 mg and its clinical antihypertensive dose is stated to be around 4 mg/day. Candesartan cilexetil is administered as a pro-drug that undergoes activation during gastrointestinal absorption. In clinical trials, candesartan cilexetil has produced a dose-dependent effect when given in dosages of 2-32 mg/day. Observed trough-to-peak blood pressure ratios support a once-daily dosage regimen. The antihypertensive effect of candesartan cilexetil 4-16 mg/day was as great as that of enalapril 10-20 mg/day and amlodipine 5 mg/day and larger than that of losartan potassium 50 mg/day. Adding candesartan cilexetil to hydrochlorothiazide 12.5-25 mg/day and amlodipine 5 mg/day led to enhanced blood-pressure reductions and was well tolerated.

Chemical Information
Molecular Weight 610.66
Formula C33H34N6O6
CAS Number 145040-37-5
Solubility (25°C) DMSO 52 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Narendar Dudhipala, et al. Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability

[2] Febry Ardiana, et al. Candesartan cilexetil

[3] Alexander Joost, et al. Candesartan cilexetil: an update

[4] Sheridan M Hoy, et al. Candesartan cilexetil: in children and adolescents aged 1 to <17 years with hypertension

[5] Greg L Plosker, et al. Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension

Related ATM/ATR Products
Tuvusertib

Tuvusertib is a selective and orally active ATR inhibitor that kills tumor cells by preventing the repair of damaged DNA with a Ki value below 1 μΜ.

ATR-IN-24

ATR-IN-24 is a ATR inhibitor.

ATM Inhibitor-6

ATM inhibitor-6 (A-193) is a selective ATM kinase inhibitor.

ATR-IN-21

ATR-IN-21 is a potent ATR inhibitor with an IC50 value of <1000 nM.

ATR-IN-23

ATR-IN-23 is a potent and selective ATR inhibitor with an IC50 of 1.5 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Candesartan Cilexetil, TCV-116 supplier, ATM/ATR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.